Zosano Pharma Corporation ZSANQ OTC

Zosano Pharma Corporation (ZSANQ) reported total assets of $48.39M and total liabilities of $15.42M for fiscal year 2021, resulting in total equity of $32.98M.

The company held $11.04M in cash and short-term investments. Total debt stood at $9.48M, with net debt of $-1.56M. The Debt-to-Equity (D/E) ratio was 0.29 (conservative).

Current ratio is 1.04, suggesting adequate short-term liquidity. Interest coverage is -157.3x (weak).

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (0/100) — Total assets $48.39M and equity $32.98M support the company's competitive scale

Overall SharesGrow Score: 25/100 with 1/7 criteria passed.

LLY

Eli Lilly and Company

$922.50

-0.76%

JNJ

Johnson & Johnson

$240.10

+0.90%

ABBV

AbbVie Inc.

$210.32

+1.86%

RHHBF

Roche Holding AG

$418.50

+1.82%

RHHBY

Roche Holding AG

$51.02

+0.65%

AZN

AstraZeneca PLC

$204.38

+1.06%

NVSEF

Novartis AG

$156.48

+0.00%

MRK

Merck & Co., Inc.

$119.96

-0.16%